Top Section/Ad
Top Section/Ad
Most recent
Cell and gene therapy company plans US expansion
More articles/Ad
More articles/Ad
More articles
-
Overnight trade was executed after interest in a ‘sizable’ purchase was made -
Bankers expect healthy deal flow as European indices are up after the break
-
Sellers are no longer waiting for better times, but want to get ahead of worse ones, bankers say
-
Bankers expect deal activity to remain strong after the break
-
Invexans completes the first ABB in the cable maker since 2005
-
European Student Housing Fund 2 sells shares at a significant loss
